Janux Therapeutics, Inc. (JANX)

Janux Therapeutics announces collaboration with Bristol Myers Squibb, boosting stock pre-market despite prior trial setbacks. Social media buzz highlights both the new partnership and lingering concerns over trial results.

About Janux Therapeutics, Inc.

Janux Therapeutics, Inc. is a biopharmaceutical company focused on developing cancer immunotherapies.
Janux Therapeutics, Inc. uses the ticker $JANX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Janux Therapeutics, Inc. (JANX) social dominance is up 65.38% from the previous week.
Janux Therapeutics, Inc. (JANX) sentiment is up 733.33% from the previous month.

Price: $13.10

Price 24-Hour Time-Series Raw Data
The stock price has seen a significant increase in pre-market trading due to the collaboration announcement with Bristol Myers Squibb, overshadowing previous disappointing trial results. This positive news appears to be driving current price action.

24-Hour: -0.83% 7-Day: 2.26% 30-Day: -4.51%

1-Year High: $37.30 on 2025-02-19
1-Year Low: $12.20 on 2026-02-05

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Janux Therapeutics, Inc. (JANX) is currently AltRank #1,522 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] +44
[--] Month: [-----] +859
[--] Months: [-----] +955
[--] Year: [-----] +1,187
1-Year High: [-----] on 2026-02-13
1-Year Low: [--] on 2025-07-06

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +2
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-10-28
1-Year Low: [--] on 2026-01-13

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-----] -35%
[--] Month: [-------] +128%
[--] Months: [---------] +92%
[--] Year: [---------] -46%
1-Year High: [-------] on 2025-12-01
1-Year Low: [---] on 2026-01-01

Engagements by network (24h): TikTok: [--] Reddit: [--] X: [---] News: [--] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -30%
[--] Month: [---] +72%
[--] Months: [-----] +48%
[--] Year: [-----] -23%
1-Year High: [---] on 2025-12-10
1-Year Low: [--] on 2026-02-16

Mentions by network (24h): TikTok: [--] Reddit: [--] X: [--] News: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Janux Therapeutics, Inc. (JANX) in the last [--] hours which is down 22% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] -19%
[--] Month: [---] +53%
[--] Months: [-----] -14%
[--] Year: [-----] +23%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-09-14

The most influential creators that mention Janux Therapeutics, Inc. in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BOSSTRADING0	[--]	[-----]	[--]	[---]
@BuyTheUgly	[--]	[--]	[--]	[--]
@foogetsrekt	[--]	[---]	[--]	[--]
@stocket_rocket	[--]	[--]	[--]	[--]
@mariostario2019	[--]	[--]	[--]	[--]

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 73%
[--] Week: 100% +50%
[--] Month: 100% +88%
[--] Months: 100% +32%
[--] Year: 100% +2%
1-Year High: 100% on 2025-03-30
1-Year Low: 7% on 2026-01-18

Most Supportive Themes:

Collaboration with Bristol Myers Squibb: (70%) Janux Therapeutics has entered into a collaboration and exclusive worldwide license agreement with Bristol Myers Squibb to develop a novel tumor-activated therapeutic for solid tumors.

Most Critical Themes:

Trial Results: (80%) Disappointing Phase [--] trial results for JANX007 are negatively impacting the stock price.
Price Decline: (10%) The stock price has fallen to a 52-week low, indicating significant downward pressure.

Social Dominance: 0.00262%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00262%
Daily Average: 0.012%
[--] Week: 0.0043% +0.0017%
[--] Month: 0.0012% -0.0034%
[--] Months: 0.0012% -0.0063%
[--] Year: 0.0012% -0.016%
1-Year High: 0.052% on 2025-12-02
1-Year Low: 0.0012% on 2026-02-16

Market Dominance: 0.0008952776099950343%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0008952776099950343%
Daily Average: 0%
1-Year High: 0.00716% on 2025-03-31
1-Year Low: 0.00086% on 2026-02-05

Market Cap: $790,342,184

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $790,342,184
Daily Average: $1,437,855,375
[--] Week: $790,342,184 -0.76%
[--] Month: $790,342,184 -4.50%
[--] Months: $790,342,184 -47%
[--] Year: $790,342,184 -63%
1-Year High: $2,206,395,138 on 2025-02-19
1-Year Low: $732,600,289 on 2026-02-05

Top Janux Therapeutics, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"this work of art ended up being meh and you think your favorite TCE-in-solid-tumor wont be Why what TCE problem does theirs cover that this doesn't "dosing regimen" lipstick on a pig. $CNTX $VIR $JANX"
X Link @RiskInhibitor 2026-02-14T21:20Z [--] followers, [---] engagements

"DEEP TRACK UPDATES 13F $XBI $IBB NEW POSITIONS: $VERA $GRAL $MLTX $ALKS $CNTA $SLNO $VSTM $ENTA $ATAI $COGT $NMPR $BLLN $IVA $JANX $ANL INCREASED $IMVT $TARS $AXSM $PCVX $MAZE $BMRN $NRIX $MBX $IMCR $CRMD $DYN $BCAX $ENGN $ANIP $DFTX $TNGX $XFOR $HELP"
X Link @BOSSTRADING0 2026-02-14T16:40Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing